Susquehanna International Group, LLP Bio Cardia, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.37 - $1.07 $19,721 - $57,031	-53,300 Reduced 26.31%	149,300 $98,000
Q3 2023 Nov 14, 2023	BUY	$0.37 - $2.85 $13,320 - $102,600	36,000 Added 21.61%	202,600 $87,000
Q2 2023 Aug 11, 2023	BUY	$1.52 - $2.8 $207,176 - $381,640	136,300 Added 449.83%	166,600 $444,000
Q1 2023 May 16, 2023	SELL	$1.87 - $2.54 $272,459 - $370,078	-145,700 Reduced 82.78%	30,300 $59,000
Q4 2022 Feb 14, 2023	BUY	$1.61 - $32.1 $3,864 - $77,040	2,400 Added 1.38%	176,000 $367,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $30.3 $39,024 - $4.93 Million	162,600 Added 1478.18%	173,600 $337,000
Q2 2022 Aug 15, 2022	SELL	$17.7 - $32.55 $267,270 - $491,504	-15,100 Reduced 57.85%	11,000 $16,000
Q1 2022 May 16, 2022	SELL	$21.3 - $39.0 $157,620 - $288,600	-7,400 Reduced 22.09%	26,100 $54,000
Q3 2021 Nov 15, 2021	BUY	$42.6 - $58.65 $1.43 Million - $1.96 Million	33,500 New	33,500 $105,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $41M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.